CMS Unveils Enhanced “Drug Dashboards” to Increase Transparency on Drug Prices

Source: CMS, Press Release, May 15, 2018

An important part of the American Patients First initiative, the Dashboards provide new information on changes in spending per drug over time

Today, the Centers for Medicare & Medicaid Services (CMS) released a redesigned version of the Drug Spending Dashboards. For the first time, the dashboards include year-over-year information on drug pricing and highlight which manufactures have been increasing their prices.

“Under President Trump’s bold leadership, CMS is committed to putting patients first and increasing transparency,” said CMS Administrator Seema Verma. “Publishing how much individual drugs cost from one year to the next will provide much-needed clarity and will empower patients and doctors with the information they need. As Secretary Azar has repeatedly pointed out, for years Medicare incentives have actually encouraged higher list prices for drugs, and this updated and enhanced dashboard is an important step to bringing transparency and accountability to what has been a largely hidden process.”

Continue Reading...
Source: CMS, Press Release, May 15, 2018